These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 7790389

  • 1. Repression of tissue inhibitor of matrix metalloproteinase expression by all-trans-retinoic acid in rat bone cell populations: comparison with transforming growth factor-beta 1.
    Overall CM.
    J Cell Physiol; 1995 Jul; 164(1):17-25. PubMed ID: 7790389
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts.
    Overall CM, Wrana JL, Sodek J.
    Connect Tissue Res; 1989 Jul; 20(1-4):289-94. PubMed ID: 2558843
    [Abstract] [Full Text] [Related]

  • 3. Cytoskeleton regulates expression of genes for transforming growth factor-beta 1 and extracellular matrix proteins in dermal fibroblasts.
    Varedi M, Ghahary A, Scott PG, Tredget EE.
    J Cell Physiol; 1997 Aug; 172(2):192-9. PubMed ID: 9258340
    [Abstract] [Full Text] [Related]

  • 4. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ, Sellers RG, Wiehr C, Melamud O, Pei D, Peehl DM.
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinases in periodontal tissue remodelling.
    Sodek J, Overall CM.
    Matrix Suppl; 1992 May; 1():352-62. PubMed ID: 1480060
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of transforming growth factor-beta 1 and bone morphogenetic protein 4 on gene expression and differentiated function of preosteoblasts.
    Zhou H, Hammonds RG, Findlay DM, Martin TJ, Ng KW.
    J Cell Physiol; 1993 Apr; 155(1):112-9. PubMed ID: 8385674
    [Abstract] [Full Text] [Related]

  • 7. Transforming growth factor beta1 inhibits collagenase 3 expression by transcriptional and post-transcriptional mechanisms in osteoblast cultures.
    Rydziel S, Varghese S, Canalis E.
    J Cell Physiol; 1997 Feb; 170(2):145-52. PubMed ID: 9009143
    [Abstract] [Full Text] [Related]

  • 8. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
    Ito K, Ryuto M, Ushiro S, Ono M, Sugenoya A, Kuraoka A, Shibata Y, Kuwano M.
    J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431
    [Abstract] [Full Text] [Related]

  • 9. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
    Braundmeier AG, Nowak RA.
    Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
    [Abstract] [Full Text] [Related]

  • 10. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
    Ito I, Fixman ED, Asai K, Yoshida M, Gounni AS, Martin JG, Hamid Q.
    Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
    [Abstract] [Full Text] [Related]

  • 11. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR.
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [Abstract] [Full Text] [Related]

  • 12. [The effects of endothelin-1 and selective endothelin receptor-type A antagonist on human renal interstitial fibroblasts in vitro].
    Tian X, Tang G, Chen Y.
    Zhonghua Yi Xue Za Zhi; 2002 Jan 10; 82(1):5-9. PubMed ID: 11953117
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes.
    Vaday GG, Schor H, Rahat MA, Lahat N, Lider O.
    J Leukoc Biol; 2001 Apr 10; 69(4):613-21. PubMed ID: 11310848
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
    Hirata M, Sato T, Tsumagari M, Shimada A, Nakano H, Hashizume K, Ito A.
    Biol Reprod; 2003 Apr 10; 68(4):1276-81. PubMed ID: 12606436
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factor Beta1 induction of tissue inhibitor of metalloproteinases 3 in articular chondrocytes is mediated by reactive oxygen species.
    Li WQ, Qureshi HY, Liacini A, Dehnade F, Zafarullah M.
    Free Radic Biol Med; 2004 Jul 15; 37(2):196-207. PubMed ID: 15203191
    [Abstract] [Full Text] [Related]

  • 16. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J, Markovic S, Wehland M, Melenhorst WB, van Goor H, Kreutz R.
    J Pharmacol Exp Ther; 2006 Jan 15; 316(1):8-16. PubMed ID: 16166267
    [Abstract] [Full Text] [Related]

  • 17. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta.
    Graham CH, Connelly I, MacDougall JR, Kerbel RS, Stetler-Stevenson WG, Lala PK.
    Exp Cell Res; 1994 Sep 15; 214(1):93-9. PubMed ID: 8082752
    [Abstract] [Full Text] [Related]

  • 18. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats.
    Deten A, Hölzl A, Leicht M, Barth W, Zimmer HG.
    J Mol Cell Cardiol; 2001 Jun 15; 33(6):1191-207. PubMed ID: 11444923
    [Abstract] [Full Text] [Related]

  • 19. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.
    Zhou J, Windsor LJ.
    J Periodontal Res; 2006 Feb 15; 41(1):47-54. PubMed ID: 16409255
    [Abstract] [Full Text] [Related]

  • 20. Modulation of the catabolic effects of interleukin-1 beta on human articular chondrocytes by transforming growth factor-beta.
    Lum ZP, Hakala BE, Mort JS, Recklies AD.
    J Cell Physiol; 1996 Feb 15; 166(2):351-9. PubMed ID: 8591995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.